Medication matters dominated the Aug. 18 meeting of the Kentucky Horse Racing Commission, which voted to change the descriptions for the drug classification schedules that are used to determine if a violation has occurred.
The Association of Racing Commissioners International's board of directors has unanimously approved a drug reclassification of stanozolol, boldenone, nandrolone, and testosterone, moving the anabolic steroids to Class 3 from Class 4.
A 45-day public comment period started March 2 on a series of rule amendments and additions under consideration by the California Horse Racing Board revising classification of drug substances and penalties for medication violations.
The California Horse Racing Board Medication Committee will consider major changes to the state's medication rules and penalties during a meeting Jan. 9 at Santa Anita Park.
Most Popular Stories
- Capps' Death is Big Loss to Louisville Equine Program
- McCraken Finishes Strong in Five-Furlong Move
- Romans Mulling Rider Options for J Boys Echo
- Goldikova, Espinoza Among Hall of Fame Inductees
- Albarado Fractures Lower Leg, Off J Boys Echo in Derby
- Santa Anita Cancels April 27 Racing
- Brisk Activity Bodes Well for OBS Spring Sale
- Nichols Canyon Connections Pointing for Iroquois Bonus
- Spending Time With New Trainer Kent Sweezey
- OBS Hips to Watch Include Tapwrit's Half Brother